HRTIS.HE Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 18:23):

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD...

Stats
Dzisiejszy wolumen	12 418.00
Średni wolumen	9 972.00
Kapitalizacja rynkowa	28.53M
EPS	€0 ( 2024-03-06 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	70.75
ATR14	€0.00600 (0.43%)

Herantis Pharma Oyj Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Herantis Pharma Oyj Finanse

Annual	2023
Przychody:	€0
Zysk brutto:	€0 (0.00 %)
EPS:	€0.0163

FY	2023
Przychody:	€0
Zysk brutto:	€0 (0.00 %)
EPS:	€0.0163

FY	2022
Przychody:	€0
Zysk brutto:	€0 (0.00 %)
EPS:	€-0.730

FY	2021
Przychody:	€0.00
Zysk brutto:	€0.00 (0.00 %)
EPS:	€-1.250

Financial Reports:

No articles found.

Herantis Pharma Oyj